Autozone Inc vs BioNTech SE - ADR — how do they compare? Autozone Inc trades at $3,043.7 (market cap $49.67B), while BioNTech SE - ADR trades at $92.8 (market cap $23.31B). The key difference: Autozone Inc is far larger — about 2.1× BioNTech SE - ADR's market cap, and Autozone Inc is trading nearer its 52-week high, BioNTech SE - ADR nearer its low. Which is the better fit depends on your goals.
| AZO | BNTX | |
|---|---|---|
Market Cap | $49.67B | $23.31B |
Sector | Consumer Cyclical | Health |
52-Week High | $4.35K | $119.34 |
52-Week Low | $2.92K | $83.89 |
Enterprise Value | $62.05B | $6.60B |
Trailing returns across standard periods
AutoZone is the premier seller of aftermarket automotive parts, tools, and accessories to do-it-yourself customers in the United States. The company derives an increasing proportion of its sales from domestic commercial customers, although its presence in its home market is still dominated by its do-it-yourself operation, which accounts for nearly 75% of sales in country. AutoZone also has a growing presence in Mexico and Brazil. AutoZone had 6,767 stores in the U.S. (6,051), Mexico (664), and Brazil (52) as of the end of fiscal 2021.
Read more on AZO →BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including COVID-19. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies.
Read more on BNTX →